Siegfried Aktie
1 062,00CHF | -8,00CHF | -0,75% |
WKN: 891169 / ISIN: CH0014284498
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 2 300 | 2 500 | 3 637 | 3 680 | 3 800 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,36 | 0,34 | 0,30 | 0,33 | 0,33 |
Bilanz (in Mio. CHF) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 590 | 651 | 826 | 945 | 983 |
Summe Anlagevermögen | 579 | 591 | 843 | 848 | 878 |
Summe Aktiva | 1 169 | 1 242 | 1 669 | 1 793 | 1 862 |
Bilanz (in Mio. CHF) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 733 | 747 | 1 061 | 1 082 | 1 103 |
Summe Eigenkapital | 436 | 496 | 608 | 711 | 758 |
Summe Passiva | 1 169 | 1 242 | 1 669 | 1 793 | 1 862 |
Adresse
Untere Brühlstrasse 4, 4800 Zofingen | |
Telefon | +41 (62) 746-11-11 |
Internet | http://www.siegfried.ch |
Management
Alexandra Brand
Independent Non-Executive Director |
Andreas Casutt
Chairman |
Beat Walti
Independent Non-Executive Director |
Christa Brügger
Senior Manager-Communications |
Elodie Carr-Cingari
Independent Non-Executive Member |
Irene Wosgien
Chief Human Resources Officer |
Isabelle Welton
Independent Non-Executive Director |
Klaus Stingl
Global Head-Business Development |
Luca Dalla Torre di Sanguinetto
Chief Legal & Sustainability Officer |
Marcel Imwinkelried
Chief Executive Officer |
Marianne Späne
Chief Business Officer-Drug Substances & Products |
Martin Schmid
Vice Chairman |
Reto Suter
Chief Financial Officer |
Stefan Randl
Chief Scientific Officer |
Wolfram Carius
Independent Non-Executive Director |